SciELO - Scientific Electronic Library Online

 
vol.31 número5Tratamiento actual del cáncer de próstata de alto riesgo y localmente avanzadoAnálisis estadístico de la influencia del virus del papiloma humano en el desarrollo del carcinoma vesical índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Actas Urológicas Españolas

versión impresa ISSN 0210-4806

Resumen

BUDIA ALBA, A. et al. Indications, results and techniques of permanent prostate brachitherapy for localized prostate cancer. Actas Urol Esp [online]. 2007, vol.31, n.5, pp.452-468. ISSN 0210-4806.

Introduction and Objective: Prostate brachytherapy is a first-line therapeutic approach for localized prostate cancer in selected patients. We present our experience in brachytherapy and a thorough review of the literature. Materials and Methods: A review of the literature and evaluation of patient's selection was done. Furthermore the implantation technique, oncological results according to the different risk groups and acute and chronic complications were also analyzed. Results: The biochemical relapse-free 10 year survival rate was 87-96% in low risk tumours and 63-86% in intermediate risk tumours. A total of 3-24% underwent urinary retention that required TURP in 0-8,7%. Other complications were urinary incontinence in 0-6,7%, proctitis in 0-15,5%, erectile dysfunction in 6,3-30%, rectal ulcer/fistula in 0-5,4%. Conclusions: Prostate brachytherapy is a safe and effective treatment in low and intermediate risk patients with prostate cancer.

Palabras clave : Prostate brachytherapy; Prostate cancer.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons